➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Medtronic
Moodys
Harvard Business School
Colorcon
Johnson and Johnson
Mallinckrodt

Last Updated: June 16, 2021

DrugPatentWatch Database Preview

Drugs in Development Information for Benzoylecgonine


Email this page to a colleague

« Back to Dashboard

What is the drug development status for Benzoylecgonine?

Benzoylecgonine is an investigational drug.

There have been 18 clinical trials for Benzoylecgonine. The most recent clinical trial was a Phase 3 trial, which was initiated on March 1st 2001.

The most common disease conditions in clinical trials are Cocaine-Related Disorders, Renal Insufficiency, and Substance-Related Disorders. The leading clinical trial sponsors are National Institute on Drug Abuse (NIDA), University of Pennsylvania, and Cincinnati MDRU.

Recent Clinical Trials for Benzoylecgonine
TitleSponsorPhase
Trial Of NS2359 For The Treatment of Cocaine DependenceSanionaPhase 2
Trial Of NS2359 For The Treatment of Cocaine DependenceThe Dana FoundationPhase 2
Trial Of NS2359 For The Treatment of Cocaine DependenceUniversity of PennsylvaniaPhase 2

See all Benzoylecgonine clinical trials

Clinical Trial Summary for Benzoylecgonine

Top disease conditions for Benzoylecgonine
Top clinical trial sponsors for Benzoylecgonine

See all Benzoylecgonine clinical trials

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Colorcon
Harvard Business School
Johnson and Johnson
McKinsey
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.